(11-454) Evaluating the Frequency of Co-prescribing of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Glucagon Like Peptide-1 (GLP-1) Agonists Among Patients with Type 2 Diabetes Mellitus
Wednesday, December 6, 2023
12:30 PM – 1:30 PM
Location: Hall E, Lower Level
Co-Author(s): Keri Montross, Mohammed Uddin, Alisha Kher, Kelcey Noble
